Yarrow Bioscience, Inc.
YARW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566044
No open-market purchases or sales by Yarrow Bioscience, Inc. insiders were filed in the last 90 days; 46 institutions reported holding it in 13F filings for Q2 2026, worth $8.79M in total; no superinvestor holds it.
Holders of 5% or more of YARW
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Yarrow Bioscience, Inc., largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Yarrow Bioscience, Inc. on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Yarrow Bioscience, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 20254:06 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 0.00%3.73K shares | −7.20 ppfrom 7.20%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20253:23 PM ET | Eventide Asset Management, LLCand 2 others | 13G/A | 0.00%0 shares | −9.99 ppfrom 9.99%Below 5% | Sep 30, 2025 | SEC |
| Nov 14, 20251:10 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 0.00%0 shares | −8.23 ppfrom 8.23%Below 5% | Sep 30, 2025 | SEC |
| Aug 14, 20254:49 PM ET | Eventide Asset Management, LLCand 2 others | 13G/A | 9.99%1.85M shares | – | Jun 30, 2025 | SEC |
| Aug 14, 20253:04 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 8.23%1.37M shares | −1.76 ppfrom 9.99% | Jun 30, 2025 | SEC |
| May 19, 20255:47 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 9.99%1.85M shares | +9.99 ppfrom 0.00% | Mar 31, 2025 | SEC |
| May 15, 20255:28 PM ET | Citadel Advisors LLCand 6 others | 13G/A | 7.20%1.10M shares | – | Mar 31, 2025 | SEC |
| May 15, 20253:03 PM ET | Cormorant Asset Management, LPand 1 other | 13G/A | 0.00%0 shares | –Below 5% | Mar 31, 2025 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Yarrow Bioscience, Inc. shares.
No Form 144 notices for Yarrow Bioscience, Inc. are on file.